CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL

被引：6
|
作者：
Pittner, BT
Jelinek, DF
Kay, NE
机构：
[1] Mayo Clin & Mayo Fdn, Dept Internal Med, Div Hematol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA
来源：
LEUKEMIA | 2004年 / 18卷 / 01期
关键词：
D O I：
10.1038/sj.leu.2403151
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：180 / 182
页数：4
相关论文
共 50 条
  • [41] Immunophenotypic clustering of B-CLL identifies subsets with different prognosis without a strict correlation, with IgVH mutational status and CD38 expression.
    Gattei, V
    Zucchetto, A
    Russo, S
    Stefanon, A
    Bomben, R
    Dal Bo, M
    Rupolo, M
    Canton, E
    Berretta, M
    Nanni, P
    Steffan, A
    Attadia, V
    Buccisano, F
    Del Poeta, G
    Colombatti, A
    Degan, M
    BLOOD, 2003, 102 (11) : 667A - 667A
  • [42] Retrospective analysis of CD38 expression in B-CLL with a maximum follow-up period of 16.7 years: Incidence and prognostic significance.
    Griesinger, F
    Kintrup, T
    Truemper, LH
    Brittinger, G
    Simon, H
    BLOOD, 2002, 100 (11) : 358B - 358B
  • [43] Retrospective analysis of CD38 expression in 102 patients with B-CLL with a maximum follow-up of 18 years:: Incidence and prognostic significance
    Jakob, Andreas
    Doll, Jasmin
    Schulte-Moenting, Juergen
    Hirsch, Friedrich W.
    ONKOLOGIE, 2006, 29 (10): : 437 - 441
  • [44] Conversion of CD38 and/or myeloid-associated marker expression status during the course of B-CLL: association with a change to an aggressive clinical course
    Chang, CC
    Cleveland, RP
    BLOOD, 2002, 100 (03) : 1106 - 1106
  • [45] SURFACE PHENOTYPE AND IMMUNOGLOBULIN HEAVY-CHAIN GENE USAGE OF B-CLL - EXPRESSION OF MYELOMONOCYTIC MARKERS IN CD5 NEGATIVE B-CLL
    NIHO, Y
    IKEMATSU, W
    IKEMATSU, H
    OHTSUKA, T
    HARADA, M
    OKAMURA, S
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1090 - 1090
  • [46] Do CLL B cells correspond to naive or memory B-lymphocytes? Evidence for an active Ig switch unrelated to phenotype expression and Ig mutational pattern in B-CLL cells
    P Oppezzo
    C Magnac
    S Bianchi
    F Vuillier
    A Tiscornia
    G Dumas
    B Payelle-Brogard
    F Ajchenbaum-Cymbalista
    G Dighiero
    O Pritsch
    Leukemia, 2002, 16 : 2438 - 2446
  • [47] Do CLL B cells correspond to naive or memory B-lymphocytes? Evidence for an active Ig switch unrelated to phenotype expression and Ig mutational pattern in B-CLL cells
    Oppezzo, P
    Magnac, C
    Bianchi, S
    Vuillier, F
    Tiscornia, A
    Dumas, G
    Payelle-Brogard, B
    Ajchenbaum-Cymbalista, F
    Dighiero, G
    Pritsch, O
    LEUKEMIA, 2002, 16 (12) : 2438 - 2446
  • [48] Different Pattern of CD154 and CD40 Expression On B-CLL and T Lymphocytes In Peripheral Blood, Bone Marrow and Lymph Node Microenvironment In B-Cell Chronic Lymphocytic Leukemia (B-CLL)
    Jaksic, Ozren
    Gizdic, Branimir
    Veic, Tajana Stoos
    Jaksic, Vlatka Pandzic
    Kusec, Rajko
    Pejsa, Vlatko
    Jaksic, Branimir
    BLOOD, 2010, 116 (21) : 1485 - 1485
  • [49] Aberrant expression of trail in B chronic lymphocytic leukemia (B-CLL) cells.
    Tiribelli, M
    Barbarotto, E
    Celeghini, C
    Michelutti, A
    Zauli, G
    Fanin, R
    Secchiero, P
    BLOOD, 2005, 106 (11) : 325B - 325B
  • [50] Expression of cyclooxygenase-2 and prostaglandins by B-1 cells and B-CLL cells
    Phipps, RP
    Pollock, SJ
    Kaur, K
    Kaufman, J
    Borrello, MA
    Graf, BA
    Nazarenko, D
    Roberts, LJ
    Morrow, JD
    Palis, J
    Ryan, DJ
    Bennett, JM
    B 1 LYMPHOCYTES IN B CELL NEOPLASIA, 2000, 252 : 293 - 300
12345